SAFETY, PHARMACOKINETICS AND PHARMACODYNAMICS OF THE NOVEL ORAL PEPTIDE THERAPEUTIC PTG-100 (ALPHA4-BETA7 INTEGRIN ANTAGONIST) IN NORMAL HEALTHY VOLUNTEERS

Richard Shames  1     Lucio Tozzi  1     Larry Mattheakis  1     THAMIL ANNAMALAI  1     ASHOK BHANDARI  1     David Liu  2    
1 PROTAGONIST THERAPEUTICS, Milpitas, United States of America
2 PROTAGONIST THERAPEUTICS,

Conference
UEG Week 2016

Citation
United European Gastroenterology Journal; 2016: 2 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing